Related Experiment Video
Updated: Jun 25, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Immunization with the 7-valent conjugate pneumococcal vaccine: impact evaluation, continuing surveillance and future
Angela Bechini1, Sara Boccalini, Paolo Bonanni
1Department of Public Health - University of Florence, Florence, Italy.
Insights
The 7-valent Pneumococcal Conjugate Vaccine (PCV) effectively protects young children against invasive pneumococcal diseases. Its widespread use demonstrates significant public health benefits, including herd immunity and reduced pneumonia rates.
Area of Science:
- Pediatric Infectious Diseases
- Vaccinology
- Public Health
Background:
- The 7-valent Pneumococcal Conjugate Vaccine (PCV) has demonstrated high efficacy in preventing invasive pneumococcal diseases (IPD) caused by vaccine serotypes in children under two years old.
- Real-world effectiveness studies in the US, Canada, and Europe confirm PCV's impact, with population-level indirect protection exceeding direct protection.
- PCV has also shown substantial benefits in reducing pneumonia and acute otitis media.
Purpose of the Study:
- To evaluate the effectiveness and impact of the 7-valent Pneumococcal Conjugate Vaccine (PCV) in routine childhood immunization.
- To assess the balance between IPD reduction from vaccine serotypes and potential increases from non-vaccine serotypes.
- To highlight the global public health imperative for PCV introduction and the development of next-generation pneumococcal vaccines.
Main Methods:
- Analysis of disease surveillance data and epidemiological studies.
- Monitoring of invasive pneumococcal disease (IPD) incidence and serotype distribution.
- Evaluation of vaccine effectiveness in real-world settings.
Main Results:
- PCV demonstrated high efficacy and effectiveness against vaccine-type IPD in young children.
- Indirect protection conferred by PCV at the population level was significant.
- A minor increase in non-vaccine serotype IPD was observed but was outweighed by the reduction in vaccine-type IPD.
- Significant reductions in pneumonia and acute otitis media were associated with PCV use.
Conclusions:
- The 7-valent PCV is highly effective in reducing pneumococcal disease burden in children, with substantial indirect protection benefits.
- Ongoing surveillance is crucial to monitor serotype replacement, and PCR-based diagnostics offer promising alternatives for pneumococcal identification.
- The World Health Organization recommends PCV introduction globally due to high mortality, and new multi-serotype vaccines require rigorous comparison to the current standard.
Abstract:
The 7-valent Pneumococcal Conjugate Vaccine (PCV) showed high efficacy against invasive pneumococcal diseases caused by vaccine serotypes in children less than 2 years-old. Its effectiveness was confirmed under routine use in the US, Canada and several European countries. Disease surveillance and several studies showed that population indirect protection outweighs direct protection of immunized subjects. A substantial impact was also confirmed on pneumonia and acute otitis media. A limited increase in IPD caused by non-vaccine serotypes was registered to date, but far below the magnitude of the beneficial reduction in IPD due to vaccine serotypes. This fact underpins the need for ongoing improved surveillance. New tests based on PCR for the identification and typing of pneumococci represent a very interesting alternative to traditional cultural tests that should be evaluated in the near future. The World Health Organization has recognized the priority to introduce PCV into the routine infant immunization schedule in all countries, due to the extremely high yearly mortality toll for pneumococcal diseases in the world (1.6 million deaths estimated). Conjugate vaccines with additional serotypes are in advanced stage of development or under evaluation. These new products need to be compared with the existing vaccine, following WHO recommendations regarding correlates of protection, in order to show their possibility to substitute the current vaccine obtaining the same impressive level of efficacy and effectiveness.
Related Concept Videos
Vaccinations
Smallpox
Principles of Disease Surveillance
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Respiratory Syncytial Virus Disease

